ClinicalTrials.gg
RecruitingNCT05608551AA TF-CBTUpdated Jul 19, 2024

Animal-assisted Trauma-focused Therapy for Children and Adolescents

An interventional study of Animal-assisted trauma-focused therapy and Standard trauma-focused therapy in Motivation and Alliance, Therapeutic, sponsored by University of Basel. Recruiting at 2 sites in Switzerland. Open to participants aged 9 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-07-19.

Sponsored by University of Basel · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Oct 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
9 Years to 17 Years
Sex
All
01

Study summary

The study aims to investigate how the inclusion of an animal into a trauma-focused group therapy program (TF-CBT) affects therapy motivation of children and adolescents suffering from post-traumatic stress. 80 children and adolescents aged 9 to 17 years are recruited for the study. Participants must have experienced at least one traumatic event leading to post-traumatic stress symptoms. Participants are randomly allocated to one of two groups: animal-assisted trauma-focused therapy (AA TF-CBT) or standard trauma-focused therapy (TF-CBT). Parallel to the groups the parents/guardians of the participating children and adolescents take part in three parent meetings.

The results of the study help to gain insights into how the inclusion of animals in trauma-focused psychotherapy can contribute to children and adolescents attending therapy, being more motivated in therapy, and can successfully complete therapy.

02

Conditions studied

  • Motivation
  • Alliance, Therapeutic

Keywords

  • PTSD
  • animal-assisted therapy
  • trauma-focused therapy
  • motivation
03

In context

Stress Disorders, Post-Traumatic

2,284 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 557 are open to participants now.

This study's planned enrollment of 80 is above the median of 70 across 1,897 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

University of Basel is the lead sponsor of 62 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 9 and 17 years
  • experienced a traumatic event
  • remembers at least one traumatic event
  • Suffering from posttraumatic stress symptoms (screened via the CATS-2; cut-off ≥ 21; cut-off must be reached by either participant or caregiver)
  • Basic knowledge of child and parents in German to be able to understand content of the session and to fill in questionnaires
  • Informed consent (given by legal guardian for participants younger than 14 years)
  • Positive or neutral attitude towards animals

Exclusion criteria

Exclusion Criteria:

  • Inability to complete questionnaires due to lack of language skills or cognitive impairment
  • Diagnosed autism spectrum disorder; Exclusion only if interaction with others and group ability is limited due to autism
  • Reported significant impairment or safety issue (e.g., active suicidal ideation, acute psychosis)
  • Known abuse of substances used for emotion regulation (e.g. cannabis, alcohol, other hard drugs)
  • Fear of domestic animals
  • Allergic reactions to domestic animals
  • Reported aggressive behavior towards animals in the past
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    AA TF-CBT

    Participants receive a 10-week animal-assisted trauma-focused group therapy.

    Behavioral: Animal-assisted trauma-focused therapy

  • Active comparator
    TF-CBT

    Participants receive a 10-week standard trauma-focused group therapy.

    Behavioral: Standard trauma-focused therapy

Interventions

  • BehavioralAnimal-assisted trauma-focused therapy

    Animal-assisted trauma-focused therapy (AA TF-CBT) is a specific form of trauma treatment, in which one or more animals are integrated into the therapy. AA TF-CBT follows a structured, standardized therapy manual.

  • BehavioralStandard trauma-focused therapy

    Standard trauma-focused therapy (AA TF-CBT) is a standardized trauma therapy following a structured manual.

06

What researchers measure

Primary outcomes

  1. Change of Therapy Motivation of children and adolescents from baseline to four weeks after treatment.

    Therapy motivation is assessed using the validated Situational Motivation Scale for Children (SMS-15, Skalski, 2019). The SMS-15 consists of 15 items answered with a 7 point likert scale. The total score equals the ratings of the 15 items on the scale. Higher scores mean a better outcome (increased motivation), lower scores mean a worse outcome (decreased motivation). The questionnaire assesses the motivation from the perception of the child.

    Time frame: before treatment (baseline), after 10 weeks of treatment (post-measurement), four weeks after treatment (follow-up)

Secondary outcomes

  1. Change of Therapeutic alliance of children and adolescents from baseline to four weeks after treatment.

    Therapeutic alliance is assessed using the german adaptation of the "Therapeutic Alliance Scales for Children" (TASC)". The TASC consists of 12 items, answered with a 4 point likert scale. The total score equals the ratings of the 12 items on the scale. Higher scores mean a better outcome (increased alliance), lower scores mean a worse outcome (decreased alliance). The questionnaire assesses the therapeutic alliance from the perception of the child.

    Time frame: before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up)

  2. Change of PTSD symptoms of children and adolescents from baseline to four weeks after treatment.

    PTSD symptoms are assessed using the validated Child and Adolescent Trauma Screen 2 (CATS 7-17, Version 2.0; Sachser et al., 2022). The questionnaire consists of 20 items, answered on a 4 point likert scale. The total score equals the ratings of the 20 items on the scale. Higher scores mean a worse outcome (increased PTSD symptoms), lower scores mean a better outcome (decreased PTSD symptoms). The questionnaire assesses the PTSD symptoms from the perception of the child as well as from the caregivers perception.

    Time frame: before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up)

  3. Change of Self-efficacy of children and adolescents from baseline to four weeks after treatment.

    Self-efficacy will be assessed via the validated Questionnaire on Resources in Child-/and Adulthood (FRKJ 8-16, Lohaus, Nussbeck, 2016). The questionnaire consists of 60 items answered on a 4 point likert scale. Higher scores mean a better outcome (increased self-efficacy), lower scores mean a worse outcome (decreased self-efficacy). The questionnaire assesses self-efficacy from the perception of the child.

    Time frame: before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up)

  4. Change of Quality of Life of children and adolescents from baseline to four weeks after treatment.

    Quality of Life is assessed using the validated Inventory for the Assessment of Quality of Life for Children and Adolescents (ILK, Mattejat \& Remschmidt, 2006). The questionnaire consists of 9 items answered on a 5 point likert scale. Lower scores mean a better outcome (increased quality of life), higher scores mean a worse outcome (decreased quality of life). The questionnaire assesses quality of life from the perception of the child.

    Time frame: before treatment (baseline), after ten weeks of treatment (post-measurement), four weeks after treatment (follow-up)

  5. Qualitative assessment of participants' perception of the group therapy at follow-up.

    Participants perception is assessed at follow-up using a semi-structured interview.

    Time frame: four weeks after treatment at follow-up

07

Study locations

2 of 2 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2022 (actual). Primary completion is estimated for Dec 2025, 38 months after the start.

Of 911 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 38 months is close to that.

Counting every sponsor, half of 937 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2022
First posted
Nov 8, 2022
StartActual
Oct 1, 2022
Primary completionEst.
Dec 31, 2025
CompletionEst.
Jul 31, 2028
Last update
Jul 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05608551
Lead sponsor
University of Basel
Responsible party
Dr. Karin Hediger (Prof. Dr., University of Basel) — Principal investigator
First posted
Nov 8, 2022
Start date
Oct 1, 2022
Primary completion
Dec 31, 2025 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Jul 19, 2024

Study contacts

Karin Hediger, Prof. Dr.
Contact
karin.hediger@unibas.ch
(+41) 061 207 65 80
Wanda Arnskötter, MSc.
Contact
wanda.arnskoetter@unibas.ch
(+41) 61 207 65 83

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion